Repare Therapeutics (RPTX) is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its…
Pharmaceuticals
Immunoprecise Antibodies (IPA.V) subsidiary Biostrand and VLAIO—Flanders Innovation and Entrepreneurship—the research fund of the Flemish regional government in Belgium—have greed on a 460,000-euro round of grant financing. This award…
Evoke Pharma is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases. The company developed, commercialized and markets GIMOTI, a nasal…
A Need for Alternatives $54.898M Market Capitalization ERYTECH Pharma (ERYP.Q) announced today that the Company has sold its US manufacturing facility to Catalent, a leading contract development and manufacturing organization…
Positive Topline Data $31.886M Market Capitalization Windtree Therapeutics Inc. (WINT.Q) announced today positive primary results with istaroxime in rapidly raising systolic blood pressure, the critical clinical objective in treating…
A big mover in Clarus Therapeutics (CRXT) today which saw the stock at one point up over 70%! The stock sees an average volume of 1,300,000 shares. At time…
Sunshine Biopharma (SBFM) is definitely bringing some sunshine for its shareholders today. At the highest price of $6.80 today, which also is all time record highs, the stock was…
Xphyto Therapeutics (XPHY.C) provided a market and product update on its Rotigotine transdermal (TDS) patch, originally developed by their German subsidiary, Vektor Pharma TF GmbH. If you’re interested in…
Numinus Wellness (NUMI.T) has moved into the implementation part of their MDMA-assisted psychotherapy trial for post-traumatic stress disorder (PTSD) clinical trial by enrolling and dosing its first volunteer. Numinus…
The COVID-19 pandemic and variant friends are almost securely in our rear-view for another year and soon the beaches will be full of people and the papers will be…